SUNNYVALE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (BCDA) [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...

Ltd. is set to report its earnings for the third quarter on Monday, January 12. The Street is anticipating a muted but stable December quarter performance, with the spotlight firmly on the TCS's ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-reports-third-quarter-2025-financial-results-and-operational-highlights ...

Digital assets (gains) losses represent the year to date fair value gains/losses of digital assets, a non-cash expense, and we are not forecasting the amounts in Q4’25.

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...

Reduced 2026 drilling and completion capital program by 18% while maintaining prior production guidance, reflecting continued capital discipline and strong capital efficiency Delivered a combined ...

Share Price, Q3 Earnings Live Updates: Focus on Jio IPO buzz, O2C growth, and reduced Russian oil imports. Get the latest ...

Bajaj Auto Q2 Results: Two-wheeler maker Bajaj Auto on Friday, November 7, posted its highest-ever quarterly revenue and profit after tax (PAT) for the second quarter of the financial year 2025-26 ...

Enrollment ongoing in BBI-355 / BBI-825 combination arm of the POTENTIATE trial Investigational new drug submission for BBI-940 on track, with a first-in-human clinical trial expected to initiate in ...

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and ...